SNPMiner Trials by Shray Alag

SNPMiner SNPMiner Trials (Home Page)

Report for Clinical Trial NCT03314272

Developed by Shray Alag, 2020.
SNP Clinical Trial Gene

Automated Versus Conventional Perioperative Glycemic Control in Adult Diabetic Patients Undergoing Cardiopulmonary Bypass Surgery

The purpose of this randomized controlled trial is to evaluate a fully automated algorithm for the establishment of glycemic control in diabetic patients and to compare the results with routine management of hyperglycemia in patients undergoing cardiopulmonary bypass surgery.

NCT03314272 Diabetes Cardiopulmonary Bypass

1 Interventions

Name: Space Glucose Control

Description: Development of a closed loop control system via Space Glucose Control that automatically infuses insulin on the basis of an automated algorithm, which integrates a continuous glucose signal, could help overcome these obstacles and permit strict glycemic control without increasing the workload.
Type: Device
Group Labels: 1

Space Glucose Control

Primary Outcomes

Description: The reduction of this percentage to less than 10% with the fully automated algorithm as clinically significant

Measure: Percentage of patients who will have a serum glucose level between 140-180mg/dl during surgery.

Time: Approximately 1 year

Purpose: Treatment

Allocation: Randomized

Parallel Assignment

There is one SNP


1 D10W

The same intervention will be repeated in case this level wasn't reached and patient will be withdrawn from the study after two failed correction and will be treated more aggressively with an infusion of D10W. --- D10W ---

HPO Nodes